Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.69 |
| ▸ | AHR | P35869 | 7/20 | 0.58 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.58 |
| ▸ | CMA1 | P23946 | 1/20 | 0.58 |
| ▸ | F7 | P08709 | 1/20 | 0.58 |
| ▸ | LTA4H | P09960 | 1/20 | 0.58 |
| ▸ | F3 | P13726 | 1/20 | 0.58 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL9446755 | 0.86 | CSNK2A1 (0.55) | CSNK2A1AHRNR4A2CMA1F7 | |
| SCHEMBL30593539 | 0.82 | GPR84 (0.69) | CSNK2A1AHRNR4A2CMA1F7 | |
| SCHEMBL1076943 | 0.82 | CSNK2A1 (0.85) | CSNK2A1AHRNR4A2CMA1F7 | |
| SCHEMBL10179972 | 0.82 | CSNK2A1 (1.00) | CSNK2A1AHRNR4A2CMA1F7 | |
| SCHEMBL5496842 | 0.82 | CSNK2A1 (0.55) | CSNK2A1AHRNR4A2CMA1F7 | |
| SCHEMBL2936352 | 0.82 | CSNK2A1 (0.60) | CSNK2A1AHRNR4A2CMA1F7 | |
| SCHEMBL15372398 | 0.82 | CSNK2A1 (0.55) | CSNK2A1AHRNR4A2CMA1F7 | |
| SCHEMBL615624 | 0.82 | CSNK2A1 (0.60) | CSNK2A1AHRNR4A2CMA1F7 | |
| SCHEMBL397084 | 0.82 | CSNK2A1 (0.55) | CSNK2A1AHRNR4A2CMA1F7 | |
| SCHEMBL1196529 | 0.82 | GPR84 (0.69) | CSNK2A1AHRNR4A2CMA1F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114805664-B | Bionic modified marine antifouling resin material, and preparation method and application thereof | 江苏苏博特新材料股份有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-112574093-B | Novel green method for preparing 3-diaryl methyl substituted indole compound | 湖南理工学院 | 2022-10-04 | — | — | CN | claimed |
| CN-114805664-A | Bionic modified marine antifouling resin material, and preparation method and application thereof | 江苏苏博特新材料股份有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114292582-B | Hyperbranched coating suitable for marine concrete, and preparation method and application thereof | 江苏苏博特新材料股份有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-114292582-A | Hyperbranched coating suitable for marine concrete, and preparation method and application thereof | 江苏苏博特新材料股份有限公司 | 2022-04-08 | — | — | CN | claimed |
| CN-112574093-A | Novel green method for preparing 3-diaryl methyl substituted indole compound | 湖南理工学院 | 2021-03-30 | — | — | CN | claimed |
| CN-103664736-B | A kind of ester derivative containing acrylamido indoles and its preparation method and application | OCEAN UNIVERSITY OF CHINA (CN) | 2015-09-30 | — | — | CN | claimed |
| CN-103694160-B | Amide derivative containing double-bond gramine and preparation method and application thereof | OCEAN UNIV CHINA | 2015-04-15 | — | — | CN | claimed |
| CN-103694160-A | Amide derivative containing double-bond gramine and preparation method and application thereof | OCEAN UNIV CHINA | 2014-04-02 | — | — | CN | claimed |
| CN-103664736-A | Ester derivative containing acrylamide indole, preparation method and application thereof | OCEAN UNIV CHINA | 2014-03-26 | — | — | CN | claimed |
| CN-1233630-C | N-substituted indole derivative preparation method | OCEAN UNIV CHINA (CN) | 2005-12-28 | — | — | CN | claimed |
| CN-1544419-A | N-substituted indole derivative preparation method | 中国海洋大学 | 2004-11-10 | — | — | CN | claimed |
| JP-8034770-A | — | — | None | — | — | JP | disclosed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | disclosed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | disclosed |
| US-12479807-B2 | Methods using HDAC11 inhibitors | VALO HEALTH, INC. (US) | 2025-11-25 | — | — | US | disclosed |
| EP-0707581-A1 | INDOLINE DERIVATIVES AS 5HT 2C? ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1996-04-24 | — | — | EP | disclosed |
| JP-H0834770-A | ANTIFOULING AGENT AGAINST UNDERWATER ADHERENT ORGANISM | IHARA CHEM IND CO LTD | 1996-02-06 | — | — | JP | disclosed |
| WO-1995023141-A1 | 4-HETEROCYCLYL-SUBSTITUTED QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS | PFIZER INC. (US) | 1995-08-31 | — | — | WO | disclosed |
| WO-1995001976-A1 | INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1995-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | HDAC3, HDAC1, HDAC4 | CSNK2A1 351/4885AHR 406/4885NR4A2 122/4885 |
| US-12479807-B2 | Methods using HDAC11 inhibitors | HDAC11, HDAC1, HDAC10 | CSNK2A1 476/4885AHR 3599/4885NR4A2 1961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.